BSF Enterprise-owned clinical and cellular agriculture company 3D Bio-Tissues (3DBT) has expanded internationally with a new office in Hong Kong, aiming to introduce its flagship cell-boosting media supplement, City-Mix, to the Chinese cultivated meat market.

3DBT will focus on the Chinese biotech industry and has begun hiring experts in R&D and sales to develop commercialization strategies, establish distribution networks, and foster manufacturing partnerships in China.

The expansion aims to tap into China's market potential and create a collaborative ecosystem in tissue engineering to expand 3DBT’s commercial presence in the industry.

Analyst QuickTake: China is an upcoming market in the cultivated meat industry, making this expansion a rather prudent decision. Cell-cultured meat was included in China’s five-year agricultural plan published by the Chinese Ministry of Agriculture and Rural Affairs in 2022. CellX, a leading Chinese cultivated meat producer, recently opened China's first large-scale pilot plant for cultivated meat production. Increasing production and the need for serum-free media can provide 3DBT opportunities required to pursue growth.